CAR-T therapy drives remission in patient with three autoimmune diseases

For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment. The patient, who once required daily blood infusions, has been in remission without needing additional treatment for a year since the CAR-T therapy. The case report, published in Med, suggests that CAR-T therapies can help treat complex and severe autoimmune diseases.